Accessibility Menu
Precision Peptide logo

Precision Peptide(OTC) PNGAF

Market Cap$14.85MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2022)-87%
5 YearN/A
1 Year+28%
1 Month-9%
$0.31
-1.43%
-0.00Today
Precision Peptide last closing stock price
MetricPriceDate
Last closeUSD 0.312026-08-25
Precision Peptide stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-3.03%USD 0.322026-08-18
1 month-9.4%USD 0.342026-07-24
3 month-6.91%USD 0.332026-05-27
Year to date+50.16%USD 0.212025-12-31
1 year+27.94%USD 0.242025-08-18
3 year-55.42%USD 0.702023-08-23
Since inception-86.69%USD 2.362022-08-25

Precision Peptide Financials at a Glance

Market Cap

$14.85MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$109.17K

Net Income (TTM)

-CA$5.98M

EPS (TTM)

-$0.15

P/E Ratio

-2.11

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.31

Volume

13,384

Open

$0.32

Previous Close

$0.31

Daily Range

$0.31 - $0.32

52-Week Range

$0.01 - $0.50

Estimated Earnings Date

N/A

PNGAF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Precision Peptide

The Precision Peptide Company Inc is a dynamic player in the packaged foods industry, focusing on the development and sale of innovative plant-based food alternatives. Operating in both Canadian and U.S. markets, the company offers a diverse product line designed to meet the growing demand for healthier food options.

Products and Services
  • Plant-based patties catering to diverse dietary preferences
  • Old Fashioned Ghee, a unique butter alternative
  • Vegan Chickn' bites, designed as a plant-based nugget option
Growth Outlook
  • Increasing consumer demand for plant-based products supports market expansion
  • Strategic partnerships with retailers enhance distribution channels
  • Focus on innovation positions the company for future growth opportunities
Financial Highlights
  • Recent quarterly revenue of CAD 16,402 reflects ongoing operational challenges
  • Trailing twelve months (TTM) revenue of CAD 64,258 indicates potential for recovery
  • Current ratio of 3.32 suggests strong liquidity position
The Precision Peptide Company Inc is positioned within a rapidly evolving market that increasingly favors plant-based alternatives. The company's commitment to innovation and quality is evident in its diverse product offerings, which cater to a growing consumer base seeking healthier food options. Despite facing operational challenges reflected in recent financial results, the company maintains a solid liquidity position, as indicated by its current ratio. The strategic focus on expanding distribution channels and enhancing product lines may provide a pathway for future growth, making it an intriguing option for potential investors interested in the packaged foods sector.
AI Generated • Aug 15, 2026

Industry

Food Products

Sector

Consumer Staples

CEO

Pratapvir Sandhu

Website

www.pangeafood.com

Headquarters

Surrey, BC V3W 0H7, CA

PNGAF Financials

Key Financial Metrics (TTM)

Gross Margin

-48.83%

Operating Margin

-4131.04%

Net Income Margin

-8804.16%

Return on Equity

-162.93%

Return on Capital

-242.25%

Return on Assets

-328.89%

Earnings Yield

-47.39%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$14.85MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

47.23M

Volume

13.38K

Avg. Volume

54.74K

Financials (TTM)

Gross Profit

-CA$764.33K

Operating Income

-CA$3.71M

EBITDA

-CA$3.65M

Operating Cash Flow

-CA$2.65M

Capital Expenditure

-CA$5.46

Free Cash Flow

-CA$2.65M

Cash & ST Invst.

CA$772.97K

Total Debt

CA$0.00

Precision Peptide Performance Analysis

Precision Peptide annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-10-31CAD 451,098728.8%
20232023-10-31CAD 211,736-53.1%
20242024-10-31CAD 8,963-95.8%
20252025-10-31CAD 35,505296.1%
Precision Peptide sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-07-31N/A
Q42025-10-31640.3%
Q12026-01-31-1.7%
Q22026-04-30-61.9%
Precision Peptide annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-10-31CAD -0.19535.1%
20232023-10-31CAD -0.2212.9%
20242024-10-31CAD -0.11-47.6%
20252025-10-31CAD -0.1531.7%
Precision Peptide sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-07-31-17.0%
Q42025-10-31-412.8%
Q12026-01-3158.9%
Q22026-04-3071.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CA$16.40K

N/A

Gross Profit

-CA$276.00

N/A

Gross Margin

-1.68%

N/A

Market Cap

$14.85MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$7.43M

N/A

Employees

2

N/A

Net Income

-CA$510.62K

-61.7%

EBITDA

-CA$479.23K

-79.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CA$772.97K

+433.7%

Total Debt

CA$0.00

-100.0%

Accounts Receivable

CA$82.05K

+87.8%

Inventory

CA$48.85K

N/A

Long Term Debt

CA$0.00

N/A

Short Term Debt

CA$0.00

-100.0%

Return on Assets

-3.29%

N/A

Return on Invested Capital

-2.21%

N/A

Free Cash Flow

-CA$862.98K

-53.7%

Operating Cash Flow

-CA$862.99K

-53.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AIXNAiXin Life International, Inc.
$0.26+0.00%
GLUCGlucose Health, Inc.
$0.31+3.33%
RELVReliv' International, Inc.
$2.00+9.29%
TOFBTofutti Brands Inc.
$0.44-3.33%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$213.05+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.09+0.01%
INTCIntel
$87.48+0.00%
BITOProShares Trust - ProShares Bitcoin ETF
$10.66+0.00%

Questions About PNGAF

What is the current price of Precision Peptide?

Precision Peptide is trading at $0.31 per share.

What is the 52-week range for Precision Peptide?

Over the past 52 weeks, Precision Peptide has traded between $0.01 and $0.50.

How much debt does Precision Peptide have?

As of the most recent reporting period, Precision Peptide reported total debt of CA$0.00.

How much cash does Precision Peptide have on hand?

Precision Peptide reported CA$568.09K in cash and cash equivalents in its most recent financial results.

What is Precision Peptide’s dividend yield?

Precision Peptide does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services